Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04696640 · ClinicalTrials.gov registry record · NA
Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04696640: Completed NA study, sponsored by University of California, Davis.
NCT04696640 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04696640, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).
Primary Outcome
Proportion of participants who have successfully established remote glucose monitoring by the end of the baseline period.
Interventions
- BEHAVIORAL Remote Patient Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2021-06-03 |
| Est. Completion | 2022-05-25 |
| Phase | NA |
What the finished NCT04696640 record still lists
NCT04696640 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Remote Patient Monitoring is the first listed.
NCT04696640 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04696640 about?
NCT04696640 is a clinical study titled "Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes". This project explores the feasibility and utility of remote glucose monitoring for a cohort of children and adolescents with type 1 diabetes (T1D) cared for at UC Davis Health (UCDH).
What is the current status of trial NCT04696640?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2021-06-03. Estimated completion is 2022-05-25.
What interventions are being tested in trial NCT04696640?
The interventions under investigation include: Remote Patient Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT04696640?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04696640's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI